Basic Information
| LncRNA/CircRNA Name | LINC00284 |
| Synonyms | NA |
| Region | GRCh38_13:43908669-44030461 |
| Ensemble | ENSG00000233725 |
| Refseq | NR_026955 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | serous ovarian cancer |
| ICD-0-3 | C56.9 |
| Methods | qRT-PCR |
| Sample | SOC tissues |
| Expression Pattern | up-regulated |
| Function Description | LINC00284 was found to be highly expressed in SOC, in association with the upregulation of the transcription factor SOX9. The high LINC00284 expression was associated with poor prognosis and proved to be an independent risk factor in patients with SOC |
| Pubmed ID | 32076467 |
| Year | 2020 |
| Title | Construction and Investigation of an LINC00284-Associated Regulatory Network in Serous Ovarian Carcinoma |
External Links
| Links for LINC00284 | GenBank HGNC NONCODE |
| Links for serous ovarian cancer | OMIM COSMIC |